Ladel C H, Blum C, Kaufmann S H
Department of Immunology, University of Ulm, Germany.
Infect Immun. 1996 May;64(5):1744-9. doi: 10.1128/iai.64.5.1744-1749.1996.
Listeria monocytogenes is an intracellular bacterium which causes an acute infectious disease in mice. Initial host resistance depends on innate immunity mediated primarily by natural killer (NK) cells followed by specific alpha/beta T cells, which are central to acquired specific immunity. Gamma/delta T lymphocytes seem to provide a link between the innate and the specific immune response. All these lymphocyte populations produce gamma interferon (IFN-gamma), which, because of its macrophage-activating potential, is central to antibacterial protection. IFN-gamma from NK cells not only contributes to early host resistance but also promotes development of protective T-cell responses of helper T type 1 (Th1) type. Here, we show that innate resistance and early IFN-gamma production in listeriosis are markedly impaired in T-cell receptor (TCR)-delta-/- but not TCR-beta-/- gene disruption mutant mice. By two-color cytofluorimetry, we demonstrate that NK cells rather than gamma/delta T lymphocytes are the major cellular source of IFN-gamma in immunocompetent mice and that IFN-gamma production by NK cells is impaired in the TCR-delta-/- mutants. Probably, reduced tumor necrosis factor production in listeria-infected TCR-delta-/- mutants contributed to impaired NK cell activation. Our data reveal a novel function of gamma/delta T cells as regulators of innate resistance against sublethal infection with an intracellular pathogen.
单核细胞增生李斯特菌是一种细胞内细菌,可在小鼠中引发急性传染病。初始宿主抵抗力取决于主要由自然杀伤(NK)细胞介导的固有免疫,随后是特异性α/βT细胞,它们是获得性特异性免疫的核心。γ/δT淋巴细胞似乎在固有免疫和特异性免疫反应之间起连接作用。所有这些淋巴细胞群体都会产生γ干扰素(IFN-γ),由于其具有巨噬细胞激活潜力,它是抗菌保护的核心。来自NK细胞的IFN-γ不仅有助于早期宿主抵抗力,还能促进1型辅助性T细胞(Th1)型保护性T细胞反应的发展。在此,我们表明,在T细胞受体(TCR)-δ-/-而非TCR-β-/-基因敲除突变小鼠中,李斯特菌病的固有抵抗力和早期IFN-γ产生明显受损。通过双色细胞荧光分析,我们证明NK细胞而非γ/δT淋巴细胞是免疫活性小鼠中IFN-γ的主要细胞来源,并且TCR-δ-/-突变体中NK细胞的IFN-γ产生受损。可能,李斯特菌感染的TCR-δ-/-突变体中肿瘤坏死因子产生的减少导致了NK细胞激活受损。我们的数据揭示了γ/δT细胞作为针对细胞内病原体亚致死感染的固有抵抗力调节剂的新功能。